,Title,count,enrolled
0,Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells,2,32
1,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,1,5000
2,Safety of UC-MSC Transfusion for ACLF Patients,1,16
3,Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma,1,16
4,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,1,16
5,Clinical Trial With MSC for Graft Versus Host Disease Treatment,1,16
6,Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium,1,16
7,Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury,1,16
8,Mesenchymal Stem Cells (MSCs) for Perianal Fistula,1,16
9,Impact of Mesenchymal Stem Cells in Knee Osteoarthritis,1,16
10,"PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS",1,16
11,Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects,1,16
12,"Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",1,16
13,Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa,1,16
14,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,1,16
15,Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS,1,19
16,Pilot Study of Stem Cell Treatment of Patients With Vocal Fold Scarring,1,16
17,Autologous Adipose-derived Regenerative Cells Injection for Treatment of Radiation-induced Rectovaginal Fistula,1,16
18,Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis,1,16
19,LYell SYndrome MEsenchymal Stromal Cells Treatment,1,15
20,Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct,1,15
21,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury,1,15
22,Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury,1,15
23,Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI),1,15
24,Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy,1,15
25,Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia,1,15
26,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,1,15
27,Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis,1,16
28,the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn,1,16
29,A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.,1,16
30,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis,1,18
31,Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells,1,18
32,Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells,1,18
33,Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa,1,18
34,Clinical Study of Allergic Rhinitis Therapy by Stem Cells,1,18
35,Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease,1,18
36,Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis,1,18
37,Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease,1,18
38,A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19,1,18
39,ADIPOA - Clinical Study,1,18
40,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis,1,18
41,Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury,1,18
42,Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation,1,18
43,A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease,1,16
44,Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF),1,18
45,Oxidative Stress as an Acute Exercise-induced Mechanism of Stem and Progenitor Cell Mobilization,1,18
46,Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis,1,18
47,Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis,1,18
48,Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation,1,18
49,Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease,1,18
50,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium,1,18
51,Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis,1,18
52,Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS),1,18
53,Hepatocyte Microbeads for Acute Liver Failure,1,17
54,Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis,1,17
55,Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia,1,15
56,Mesenchymal Stem Cells and Subclinical Rejection,1,15
57,Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro,1,15
58,Reconstruction of Jaw Bone Using Mesenchymal Stem Cells,1,13
59,A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects,1,15
60,Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients,1,15
61,Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis,1,14
62,"Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)",1,14
63,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke,1,14
64,Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy,1,14
65,Intravitreal Injection of MSCs in Retinitis Pigmentosa,1,14
66,Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease,1,14
67,Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.,1,14
68,Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury,1,14
69,Mesenchymal Stem Cells in Knee Cartilage Injuries,1,13
70,Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis,1,13
71,ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis,1,15
72,Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis,1,13
73,Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B,1,12
74,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial,1,12
75,Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA,1,12
76,Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis,1,12
77,hCT-MSC Infusion in Adults With Autism Spectrum Disorder,1,12
78,Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells,1,12
79,"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects",1,12
80,The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia,1,12
81,hCT-MSCs for Children With Autism Spectrum Disorder (ASD),1,12
82,Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia,1,12
83,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD,1,15
84,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP,1,15
85,Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.,1,15
86,Haploidentical Stem Cell Transplantation in Neuroblastoma,1,15
87,AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses,1,15
88,Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP),1,15
89,Stem Cell Therapy to Improve Burn Wound Healing,1,15
90,A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring,1,15
91,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus,1,15
92,Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy,1,15
93,Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones,1,15
94,Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas,1,15
95,Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia,1,15
96,Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes,1,15
97,Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease,1,15
98,Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders,1,15
99,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease,1,15
100,Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue,1,15
101,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism,1,15
102,Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD),1,15
103,Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD),1,15
104,Gingival Crevicular Fluid Bone Morphogenetic Protein - 2 Release Profile Following the Use of Perforated Membrane,1,15
105,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head,1,15
106,Comparative Effectiveness of Arthroscopy and Non-Arthroscopy Using Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium for Osteoartrithis,1,15
107,Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis,1,15
108,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke,1,15
109,Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis,1,15
110,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS,1,15
111,Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones,1,19
112,Mesenchymal Stem Cell Therapy for Lung Rejection,1,19
113,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),1,24
114,Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism,1,20
115,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,1,20
116,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA,1,20
117,Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke,1,20
118,Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia,1,20
119,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD,1,20
120,Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19),1,20
121,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,1,20
122,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI,1,20
123,Angiographic Delivery of AD-MSC for Ulcerative Colitis,1,20
124,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,1,20
125,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease,1,20
126,"Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury",1,20
127,Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy,1,20
128,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,1,20
129,Mesenchymal Stem Cell Therapy for Liver Cirrhosis,1,20
130,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease,1,20
131,MSC Therapy in Liver Transplantation,1,20
132,"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",1,20
133,Mesenchymal Stem Cells in Critical Limb Ischemia,1,20
134,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,1,20
135,Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells,1,20
136,Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC),1,20
137,Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage),1,20
138,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis,1,20
139,Mesenchymal Stem Cells in Early Rheumatoid Arthritis,1,20
140,Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells,1,20
141,Mesenchymal Stromal Cells for Degenerative Meniscus Injury,1,20
142,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,1,21
143,"Allogeneic ABCB5-positive Stem Cells for Treatment of DFU ""Malum Perforans""",1,23
144,Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF,1,23
145,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,1,23
146,A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure,1,23
147,MSC and BMMNC in Type 2 Diabetes Mellitus,1,22
148,Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM),1,22
149,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,1,22
150,Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis,1,22
151,A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects,1,22
152,Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis,1,22
153,Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients,1,21
154,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,1,21
155,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,1,20
156,"Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",1,21
157,Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration,1,21
158,An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease,1,21
159,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,1,21
160,An Follow-Up Study of Liver Cirrhosis,1,21
161,A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,1,21
162,Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease,1,20
163,Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease,1,20
164,Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis,1,20
165,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis,1,20
166,Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.,1,20
167,UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers,1,20
168,Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS,1,20
169,Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction,1,19
170,Descartes-25 in Relapsed/Refractory Multiple Myeloma,1,20
171,Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI,1,20
172,Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.,1,20
173,Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis,1,20
174,Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis,1,20
175,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty,1,20
176,Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells,1,20
177,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA,1,20
178,Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease,1,20
179,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure,1,20
180,Bone Regeneration With Mesenchymal Stem Cells,1,20
181,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis,1,20
182,Intermediate Size Expanded Access for the Use of ExoFlo in the Treatment of Abdominal Solid Organ Transplant Patients Who Are at Risk of Worsening Allograft Function With Conventional Immunosuppressive Therapy Alone,1,20
183,RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):,1,20
184,Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.,1,20
185,Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair,1,20
186,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases,1,20
187,Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).,1,20
188,Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis,1,20
189,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer,1,20
190,Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs),1,20
191,The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital,1,19
192,"Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",1,19
193,Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.,1,19
194,Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle,1,19
195,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI,1,20
196,A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),1,20
197,Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease,1,20
198,Stem Cell Fistula Plug in Perianal Crohn's Disease,1,20
199,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia,1,20
200,A Novel Therapeutic Treatment of Pyoderma Gangrenosum,1,20
201,"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion",1,20
202,Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting,1,20
203,Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients,1,20
204,Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis,1,20
205,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF,1,20
206,Repeated Mesenchymal Stem Cell Injections in ALS,1,20
207,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease,1,20
208,MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound,1,20
209,Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease,1,20
210,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases,1,20
211,Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts,1,20
212,Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease,1,20
213,Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies,1,20
214,Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles,1,20
215,Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect,1,20
216,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia,1,20
217,hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis,1,20
218,Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis,1,20
219,The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS,1,20
220,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes,1,20
221,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS,1,20
222,Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease,1,20
223,Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia,1,12
224,"Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.",1,12
225,Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy,1,12
226,Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden,1,7
227,Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease,1,7
228,Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas,1,7
229,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,1,7
230,Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),1,7
231,Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject With Lupus Nephritis,1,7
232,Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis,1,7
233,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,1,7
234,Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease,1,7
235,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,1,7
236,Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells,1,7
237,Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells,1,7
238,Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease,1,6
239,Stem Cells for Uremic Calciphylaxis Patients,1,7
240,Tolerance by Engaging Antigen During Cellular Homeostasis,1,6
241,Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa,1,6
242,Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS,1,6
243,Articular Cartilage Resurfacing With Mesenchymal Stem Cells In Osteoarthritis Of Knee Joint,1,6
244,Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis,1,6
245,Alzheimer's Disease Stem Cells Multiple Infusions,1,6
246,Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation,1,6
247,Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell,1,6
248,Mesenchymal Stem Cells for The Treatment of Frailty Syndrome,1,6
249,MSC for Occlusive Disease of the Kidney,1,6
250,Intra-Osseous Co-Transplant of UCB and hMSC,1,6
251,ADMSCs for the Treatment of Systemic Sclerosis,1,7
252,Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn,1,7
253,Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation,1,6
254,Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia,1,9
255,Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia,1,9
256,Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia,1,9
257,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),1,9
258,Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke,1,9
259,Safety of Wharton Jelly in Erectile Dysfunction,1,9
260,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans®,1,9
261,Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage,1,9
262,Efficacy of Wharton Jelly in Erectile Dysfunction,1,9
263,Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®,1,9
264,Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia,1,9
265,Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease,1,9
266,The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy,1,9
267,Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101),1,8
268,The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease,1,9
269,Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders,1,8
270,A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis,1,8
271,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,1,8
272,Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS,1,8
273,Autologous Mesenchymal Stromal Cells for Multiple Sclerosis,1,8
274,Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation,1,8
275,Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study,1,8
276,Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.,1,8
277,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,1,8
278,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED,1,8
279,Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease,1,6
280,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,1,6
281,BC-101 in Treatment of Nasolabial Fold Wrinkles,1,9
282,Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients,1,3
283,Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study,1,5
284,Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis,1,5
285,ENgineered Tissue Repair of BronchopleUral fiSTula,1,5
286,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial,1,4
287,Stem Cell in Acute Myocardial Infarction,1,4
288,Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,1,4
289,Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED),1,4
290,Mesenchymal Stem Cell and Islet Co-transplantation,1,3
291,"PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells",1,3
292,Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling,1,3
293,Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis,1,3
294,The Effects of Antibiotic Combinations on Stem Cells,1,3
295,Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers,1,5
296,Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone,1,3
297,Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.,1,2
298,Stem Cell Fistula Plug in Post Surgical Leak Fistulas,1,2
299,Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta,1,2
300,Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia,1,1
301,Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells,1,1
302,Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS),1,1
303,Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP,1,1
304,Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease,1,1
305,Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection,1,1
306,When to Apply to Which Patient in MSC?,1,1
307,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD,1,5
308,Stem Cell Coated Fistula Plug in Patients With Crohn's RVF,1,5
309,Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis,1,6
310,Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke,1,5
311,Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint,1,6
312,Mesenchymal Stromal Cells in Kidney Transplant Recipients,1,6
313,ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery,1,6
314,Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction,1,6
315,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,1,6
316,Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE,1,6
317,Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).,1,6
318,Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage,1,6
319,Safety and Efficacy of YB-1113 in Treatment of POI,1,6
320,Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies,1,6
321,"Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",1,6
322,A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound,1,5
323,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial,1,5
324,In Vivo Tracking of USPIO Labeled MSC in the Heart,1,5
325,Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta,1,5
326,Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis,1,5
327,Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response,1,5
328,Mesenchymal Stem Cells (MSC) for Ovarian Cancer,1,5
329,Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy,1,5
330,Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients,1,5
331,Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis,1,5
332,The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease,1,5
333,Pediatric MSC-AFP Sub-study for Crohn's Fistula,1,5
334,Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB,1,5
335,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,1,9
336,Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy,1,9
337,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,1,12
338,Synovial Tissue and Fat Pad Stromal Vascular Fraction Bioengineering in Patients With Knee Articular Cartilage Injury,1,10
339,Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells,1,10
340,Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis,1,10
341,Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1),1,10
342,Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord,1,10
343,Concomitant Use of Buccal Fat Pad Derived Cells and Autogenous Bone in Alveolar Cleft Osteoplasty,1,10
344,The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans,1,10
345,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,1,10
346,Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,1,10
347,Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury,1,10
348,Safety of Mesenchymal Stem Cell Extracellular Vesicles (BM-MSC-EVs) for the Treatment of Burn Wounds,1,10
349,Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment,1,10
350,Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis,1,10
351,Follow-up Study for Participants Jointstem Clinical Trial,1,11
352,Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,1,10
353,Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD),1,10
354,Safety and Tolerability Study of MSC Exosome Ointment,1,10
355,Mesenchymal Stem Cells and Myocardial Ischemia,1,10
356,A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells,1,10
357,Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .,1,10
358,Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy,1,10
359,The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants,1,10
360,Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema,1,10
361,A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation,1,10
362,CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage,1,10
363,Reduce Immunosuppression With Atmp in NS ChildrEn,1,11
364,BMT Autologous MSCs for GvHD,1,11
365,Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,1,10
366,MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer,1,12
367,A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers,1,12
368,Treatment of Tendon Injury Using Mesenchymal Stem Cells,1,12
369,A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure),1,12
370,Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma,1,12
371,Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue,1,12
372,The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction,1,12
373,Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A,1,12
374,Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD),1,12
375,Transplantation of hAMSCs for Woman With DOR,1,12
376,Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem),1,12
377,Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD),1,12
378,Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI),1,12
379,Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients,1,11
380,Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia,1,12
381,Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI),1,12
382,"Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",1,12
383,Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder,1,12
384,Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study,1,12
385,Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection,1,12
386,Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients,1,12
387,Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy,1,11
388,Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H),1,11
389,Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion,1,11
390,Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis,1,11
391,MSC EVs in Dystrophic Epidermolysis Bullosa,1,10
392,Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease,1,10
393,Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants,1,9
394,Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome,1,9
395,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,1,10
396,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,1,10
397,Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF),1,10
398,Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease,1,10
399,Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis,1,10
400,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease",1,10
401,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction,1,10
402,Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells,1,10
403,Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease,1,10
404,Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy,1,10
405,Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation,1,10
406,"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease",1,9
407,Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,1,10
408,Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,1,9
409,A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease,1,9
410,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,1,9
411,Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage,1,9
412,The Clinical Trial of ADR-001 for IgA Nephropathy,1,9
413,Cellular Immunotherapy for Septic Shock: A Phase I Trial,1,9
414,Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis,1,9
415,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1),1,9
416,Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study,1,9
417,Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation,1,9
418,AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial,1,9
419,Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI,1,10
420,Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction,1,10
421,hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury,1,10
422,Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy,1,10
423,Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction,1,10
424,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,1,10
425,Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies,1,10
426,Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,1,10
427,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients",1,10
428,Fertility Restoration Using Autologous Mesenchymal Stem Cells,1,10
429,Clinical Trials of Regeneration for Periodontal Tissue,1,10
430,Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias,1,10
431,Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria,1,10
432,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair,1,10
433,Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS),1,10
434,Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease,1,10
435,Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD,1,10
436,Adipose Stem Cells for Traumatic Spinal Cord Injury,1,10
437,Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).,1,10
438,Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients,1,10
439,Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries,1,10
440,Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC,1,10
441,Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction,1,10
442,Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema,1,10
443,Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD),1,10
444,Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS),1,10
445,Tissue Engineered Constructs for Alveolar Cleft Repair,1,10
446,Progenitor Potential of Mesenchymal Stem Cells in Palatal Tissue Harvested From Molar and Premolar Sites,1,10
447,Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head,1,23
448,Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA,1,24
449,Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis,1,700
450,Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes,1,24
451,Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease,1,73
452,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,1,72
453,REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient),1,72
454,Allogeneic Mesenchymal Stem Cells for Osteoarthritis,1,72
455,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER),1,70
456,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,1,70
457,Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA),1,70
458,The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus,1,70
459,Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants,1,69
460,Safety Study of Mesenchymal Stem Cells and Spinal Fusion,1,69
461,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),1,66
462,Assessment of the Efficacy of Stromal Vascular Fraction Treatment for Knee Osteoarthritis,1,66
463,Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents,1,66
464,Treatment of Severe Infections With Mesenchymal Stem Cells,1,66
465,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency,1,66
466,Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products,1,65
467,AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery,1,65
468,The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT),1,65
469,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers,1,64
470,PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM),1,63
471,PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),1,62
472,Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty,1,62
473,Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair,1,62
474,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial,1,62
475,Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes,1,61
476,Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure,1,74
477,"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)",1,74
478,Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes,1,75
479,Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone,1,80
480,The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars,1,90
481,A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease,1,90
482,Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars,1,90
483,Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy,1,86
484,Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture,1,85
485,Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia,1,84
486,MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs,1,84
487,Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease,1,82
488,Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction,1,82
489,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS,1,81
490,Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE),1,81
491,Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury,1,80
492,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19,1,75
493,A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells,1,80
494,Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction,1,80
495,Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells,1,80
496,Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula,1,80
497,Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome,1,80
498,Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients,1,80
499,Stem Cell and Conditioned Medium for Cerebral Palsy,1,78
500,Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease,1,77
501,Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy,1,76
502,Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg,1,76
503,Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.,1,75
504,Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS),1,60
505,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,1,60
506,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,1,60
507,Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial,1,55
508,Comparative Study Between Fat Injection And Platelet Rich Plasma In Post Burn Facial Scar,1,60
509,Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD).,1,60
510,The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,1,60
511,Autologous Mesenchymal Stromal Cell Therapy in Heart Failure,1,59
512,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers,1,59
513,Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids,1,58
514,"MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer",1,57
515,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers,1,56
516,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,1,56
517,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",1,55
518,Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy,1,55
519,"A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",1,55
520,A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection,1,60
521,Autologous Stem Cell Study for Adult TBI (Phase 2b),1,55
522,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,1,55
523,Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously,1,54
524,Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis,1,54
525,A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis,1,54
526,Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis,1,53
527,"Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",1,53
528,Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD,1,52
529,Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD,1,52
530,The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression,1,52
531,A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral,1,52
532,Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells,1,60
533,Mesenchymal Stem Cell Transplantation for Osteoarthritis,1,60
534,Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis,1,60
535,Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection,1,60
536,Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip,1,60
537,Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis,1,60
538,ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome,1,60
539,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",1,60
540,Safety of Autologous MSC Infusion to Treat Epilepsy,1,60
541,Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial,1,60
542,MSC Intratissular Injection in Crohn Disease Patients,1,60
543,Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.,1,60
544,Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,1,60
545,Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells,1,60
546,A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy,1,60
547,Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II),1,60
548,Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,1,60
549,Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST),1,60
550,Allogeneic Mesenchymal Stem Cells in Osteoarthritis,1,60
551,A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure,1,60
552,Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022,1,60
553,Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction,1,60
554,Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment,1,60
555,Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START),1,60
556,Clinical Plan of Ischemic Stroke,1,60
557,Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients,1,60
558,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,1,60
559,MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial),1,60
560,Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis,1,90
561,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,1,90
562,Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2),1,90
563,A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS,1,169
564,Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases,1,200
565,microRNAs Role in Pre-eclampsia Diagnosis,1,200
566,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,1,200
567,Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis,1,200
568,Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke,1,200
569,Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb),1,200
570,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,1,200
571,Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD),1,192
572,Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease,1,182
573,Plasmonic Nanophotothermal Therapy of Atherosclerosis,1,180
574,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD),1,180
575,Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts,1,165
576,Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis,1,200
577,hCT-MSC in Children With Autism Spectrum Disorder,1,164
578,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.,1,164
579,Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI),1,160
580,Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency,1,158
581,Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation,1,158
582,MSC for Treatment of cGVHD After Allo-HSCT,1,152
583,Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors,1,150
584,Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty,1,150
585,National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study),1,150
586,Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting,1,150
587,Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA),1,140
588,WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction,1,200
589,Stem Cells Predicting Orthopedic Outcomes,1,203
590,A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis,1,140
591,WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease,1,300
592,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,1,600
593,Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.,1,566
594,Stem Cell Ophthalmology Treatment Study II,1,500
595,Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES),1,480
596,Bone Marrow Mesenchymal Stem Cell Derived EVs for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial,1,400
597,Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease,1,330
598,Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure.,1,315
599,Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis,1,300
600,Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis,1,300
601,A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With COVID-related Pneumonia,1,300
602,Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China,1,300
603,Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear,1,300
604,Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy,1,210
605,Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease,1,278
606,Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis,1,266
607,Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients,1,263
608,A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,1,260
609,Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD),1,260
610,Treatment of Cartilage Defects With Peripheral Blood Stem Cells,1,252
611,The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain,1,242
612,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2),1,240
613,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis,1,240
614,MSCs for Prevention of MI-induced HF,1,240
615,Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI),1,220
616,Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft,1,140
617,Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy,1,136
618,Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients,1,90
619,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),1,100
620,Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus,1,102
621,Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration,1,100
622,Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment,1,100
623,Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells,1,100
624,Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis,1,100
625,Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair,1,100
626,Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction,1,100
627,Stem Cells for Bronchopulmonary Dysplasia,1,100
628,Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy,1,100
629,A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis,1,100
630,Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function,1,100
631,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,1,100
632,Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect,1,103
633,Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,1,100
634,Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain,1,100
635,A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD),1,99
636,Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease,1,98
637,Cord Blood Expansion on Mesenchymal Stem Cells,1,98
638,"CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",1,94
639,Dysfunctions of Human Muscle Stem Cells in Sepsis,1,93
640,Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis,1,92
641,A Study of UCB and MSCs in Children With CP: ACCeNT-CP,1,91
642,Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy,1,91
643,To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.,1,90
644,Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI,1,102
645,Mesenchymal Stem Cells to Treat Type 2 Diabetes,1,103
646,The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa,1,135
647,Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome,1,120
648,Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT,1,130
649,Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female,1,130
650,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST),1,129
651,Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial,1,129
652,Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure,1,125
653,Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS,1,120
654,Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients,1,120
655,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,1,120
656,Mesenchymal Stem Cell Therapy for Knee Osteoarthritis,1,120
657,Co-transplantation of MSC in the Setting of Allo-HSCT,1,120
658,Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.,1,120
659,Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients,1,120
660,Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury,1,104
661,A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis,1,120
662,Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis,1,118
663,Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF),1,115
664,Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS,1,115
665,Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot,1,112
666,Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application,1,110
667,Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis,1,108
668,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation,1,107
669,Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion,1,106
670,Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction,1,106
671,Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI),1,105
672,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,1,52
673,Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP),1,50
674,Treatment of Steroid Resistant GVHD by Infusion MSC,1,50
675,The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells,1,30
676,Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis,1,30
677,Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,1,30
678,Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis,1,30
679,The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study),1,30
680,A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis,1,30
681,Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation,1,30
682,Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes,1,30
683,Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease,1,30
684,Study on Shoulder Arthritis Treatment With Intra-articular Injections of Autologous Bone Marrow Aspirate.,1,30
685,Allogeneic MSC Treatment for Pulmonary Emphysema,1,30
686,Mesenchymal Stem Cells for Radiation-induced Xerostomia,1,30
687,Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD),1,30
688,Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects,1,30
689,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial,1,30
690,Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy,1,30
691,Clinical Efficacy of Exosome in Degenerative Meniscal Injury,1,30
692,Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC),1,30
693,Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing,1,30
694,Bone Marrow Derived Stem Cell Transplantation in T2DM,1,30
695,Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell,1,30
696,Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy,1,30
697,Mesenchymal Stem Cell Therapy in Multiple System Atrophy,1,30
698,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,1,30
699,Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial,1,30
700,Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,1,30
701,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus,1,30
702,Boost Brittle Bones Before Birth,1,30
703,Mesenchymal Stromal Cells and Osteoarthritis,1,30
704,Mesenchymal Stemcells for Radiation Induced Xerostomia,1,30
705,Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease,1,30
706,Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research,1,30
707,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,1,30
708,Microneedle Versus Fractional CO₂ Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women,1,30
709,Clinical Use of Stem Cells for the Treatment of Covid-19,1,30
710,Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock,1,30
711,Intraspinal Transplantation of Autologous ADRC in ALS Patients,1,30
712,"A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",1,30
713,Study of Descartes-30 in Acute Respiratory Distress Syndrome,1,30
714,Senescence in Chronic Kidney Disease,1,30
715,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty,1,30
716,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,1,30
717,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,1,30
718,Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis,1,30
719,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial,1,30
720,"Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers",1,30
721,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke,1,30
722,Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia,1,30
723,Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease,1,30
724,Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells,1,30
725,Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture,1,30
726,Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.,1,30
727,Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells,1,30
728,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,1,30
729,Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury,1,30
730,Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis,1,30
731,Human Amniotic Membrane and Mesenchymal Stem Cells Composite,1,24
732,Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis,1,24
733,Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study,1,24
734,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear),1,24
735,Mesenchymal Stromal Cells in Living Donor Kidney Transplantation,1,24
736,A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.,1,24
737,Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease,1,24
738,Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS,1,24
739,A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers,1,24
740,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC),1,24
741,Effects of ASC Secretome on Human Osteochondral Explants,1,24
742,Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis,1,24
743,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis,1,24
744,REcycled CartiLage Auto/Allo IMplantation,1,25
745,Mesenchymal Stem Cells for the Treatment of MS,1,24
746,The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause,1,24
747,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,1,24
748,Use of UC-MSCs for COVID-19 Patients,1,24
749,"Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)",1,24
750,Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis,1,24
751,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy,1,24
752,hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility,1,24
753,Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis,1,24
754,Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures,1,24
755,A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy,1,24
756,Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation,1,24
757,Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells,1,25
758,Menstrual Blood Stem Cells in Severe Covid-19,1,29
759,Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome,1,27
760,Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.,1,28
761,A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,1,28
762,iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation,1,28
763,Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency,1,28
764,A Study of ADR-001 in Patients With Liver Cirrhosis,1,27
765,Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency,1,27
766,Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD,1,27
767,Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas,1,27
768,Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy,1,27
769,Treatment of Gingival Recession Using Mesenchymal Stem Cells,1,27
770,Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy,1,27
771,A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis,1,27
772,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),1,25
773,Safety & Efficacy of AlloRx SC® in PTHS Patients,1,26
774,Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis,1,26
775,"Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis",1,26
776,Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome,1,26
777,Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells,1,26
778,Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip,1,26
779,Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.,1,26
780,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,1,26
781,Effects of Muscle Energy Technique in Knee Osteoarthritis Patients,1,26
782,Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia,1,25
783,Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells,1,25
784,Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis,1,30
785,Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis,1,30
786,Parkinson's Disease Therapy Using Cell Technology,1,50
787,Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients,1,42
788,Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia,1,45
789,Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease,1,45
790,Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure,1,45
791,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,1,45
792,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,1,44
793,MSC-Exos Promote Healing of MHs,1,44
794,Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ),1,44
795,Mesenchymal Stem Cells in Rotator Cuff Repair,1,44
796,Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer,1,43
797,Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia,1,43
798,Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction,1,43
799,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT,1,42
800,Stem Cell Injection in Cancer Survivors,1,46
801,Hypoxia and Inflammatory Injury in Human Renovascular Hypertension,1,42
802,Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy,1,42
803,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis,1,41
804,The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis,1,40
805,Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease,1,40
806,UC-MSC Transplantation for Left Ventricular Dysfunction After AMI,1,40
807,Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures,1,40
808,Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer,1,40
809,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,1,40
810,Immune Modulation by Exosomes in COVID-19,1,40
811,Mesenchymal Stem Cells After Renal or Liver Transplantation,1,40
812,Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD,1,45
813,A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union,1,46
814,"Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars",1,40
815,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,1,48
816,Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury,1,50
817,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis,1,50
818,Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow,1,50
819,Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence,1,50
820,Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI),1,50
821,MSCs Therapy for Cerebral Palsy,1,50
822,Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis,1,50
823,Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy,1,50
824,The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring,1,50
825,A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction,1,50
826,Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant,1,49
827,Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis,1,48
828,Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells,1,46
829,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,1,48
830,NEPHSTROM for Diabetic Kidney Disease,1,48
831,Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke,1,48
832,Inflammatory Response After Muscle and Skeleton Trauma,1,48
833,Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury,1,48
834,A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor,1,48
835,"Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",1,48
836,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,1,47
837,Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures,1,46
838,Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease,1,46
839,Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer,1,46
840,Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients,1,40
841,Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer,1,40
842,SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.,1,31
843,Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee,1,32
844,Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP),1,36
845,Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.,1,35
846,Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells,1,35
847,Mobilization of Mesenchymal Stem Cells During Liver Transplantation,1,35
848,Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration,1,35
849,IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.,1,35
850,Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease,1,35
851,Mesenchymal Stem Cells: Alterations in Genome,1,35
852,Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease,1,33
853,Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.,1,33
854,Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients,1,33
855,Freeze-dried Bovine Hydroxyapatite/Secretome Composite for Bone Defects,1,32
856,Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula,1,36
857,Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD,1,32
858,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,1,32
859,"Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers",1,32
860,Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD),1,32
861,"Biochemical Correction of Severe EB by Allo HSCT and ""Off-the-shelf"" MSCs",1,32
862,Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells,1,32
863,The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study),1,31
864,Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study,1,31
865,Intravenous Stem Cells After Ischemic Stroke,1,31
866,Allogeneic ABCB5-positive Stem Cells for Treatment of CVU,1,31
867,Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia,1,31
868,Mesenchymal Stem Cells for Age-Related Frailty,1,36
869,Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis,1,36
870,Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease,1,40
871,Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial,1,40
872,Impact of Semaglutide on CD34+ EPC and Fat Derived MSC,1,40
873,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,1,40
874,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,1,40
875,Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）,1,40
876,Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease,1,40
877,Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome,1,40
878,Mesenchymal Stem Cells for the Treatment of COVID-19,1,40
879,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease,1,40
880,Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19,1,40
881,Stem Cell Therapy for Chronic Kidney Disease,1,40
882,Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis,1,40
883,Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation,1,40
884,Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells,1,36
885,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,1,40
886,Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix,1,40
887,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),1,40
888,Mesenchymal Stromal Cells (MSC´s) in Renal Lupus,1,39
889,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,1,39
890,A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke,1,38
891,PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study),1,37
892,Safety and Efficacy of Stem Cell Therapy in Patients With Autism,1,37
893,Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.,1,36
894,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,1,36
895,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma,1,36
896,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),1,1
